Revolutionizing Oncology with Artificial Intelligence and Strategic Alliances

The digital health sector in Spain has experienced remarkable growth and maturation in recent years. Innovative proposals are creating a robust ecosystem that not only attracts the attention of technological giants but also generates significant social impact. In this context, Vitalera, formerly known as HumanITCare, emerges as a key player by putting the human being at the center of digital transformation in healthcare.

A New Chapter for Vitalera

The Barcelona-based startup vitalera (formerly humanITcare) has taken a step forward, transforming into Vitalera and marking the beginning of an exciting new phase. Since its founding in 2018, Vitalera has gained recognition in the national and international digital health landscape. This name change symbolizes a qualitative leap in its evolution, especially with the addition of new allies that will propel its digital solutions to a new level, with the United States in its sights.

Strategic Alliances with Google.org and The Ricky Rubio Foundation

The recent collaboration with Google.org and The Ricky Rubio Foundation highlights Vitalera's relevance in the digital oncology field. Google.org, through its GrowAI program, will invest 200,000 euros in Vitalera to develop an advanced artificial intelligence program. This program will focus on improving the monitoring of oncology patients, allowing doctors to anticipate possible relapses without straining the healthcare system.

Nuria Pastor, CEO and founder of Vitalera, emphasizes, "We provide doctors with valuable information to anticipate relapses in oncology patients and treat them without straining the healthcare system."

Additionally, The Ricky Rubio Foundation, known for its focus on health and sports, joins Vitalera to improve the quality of life for young oncology patients. Ricky Rubio states, "The Vitalera platform allows us to store and analyze data more effectively, facilitating more efficient research in oncology patients aged 18 to 35."

Innovation and Technology at the Service of Oncology

Vitalera has been selected for INCO's Social Tides program, which supports innovative startups to maximize their social impact. The startup specializes in developing digital tools that monitor biomarkers for chronic diseases such as cardiology, pulmonology, diabetes, and especially oncology. These tools not only democratize access to gene therapies but also allow patients to receive personalized care from the comfort of their homes.

Vitalera's technology uses artificial intelligence machine learning models for its intelligent alarm system. This system predicts adverse events and supports clinical decision-making, significantly improving resource management in healthcare.

International Expansion: The United States on the Horizon

With a solid base in Spain and Latin America, Vitalera is preparing to expand into new markets, with a special focus on the United States. The company has attracted the attention of healthcare professionals, hospitals, pharmaceutical companies, and insurers in these territories. Nuria Pastor concludes, "The United States is on our radar, and in this market, we want to contribute to forming new tools that, in oncology and due to the particularities of the North American market, we believe will have great potential in the future."

Conclusion

Vitalera represents the forefront of digital health, combining advanced technology and strategic alliances to improve the lives of oncology patients. With its focus on artificial intelligence and planned expansion into the United States, Vitalera is well-positioned to lead the next wave of innovation in the digital health sector. The startup is not only transforming access to healthcare but also ensuring that technology truly benefits those who need it most.

‍